REG - Primary Health Props - Director/PDMR Shareholding

Primary Health PropertiesAnnouncement

09/05/2024 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240509:nRSI8435Na&default-theme=true

RNS Number : 8435N  Primary Health Properties PLC  09 May 2024

Primary Health Properties PLC

PDMR dealing

On 8 May 2024, the Remuneration Committee of Primary Health Properties PLC
(the "Company" or "PHP") made the following award of nil-cost options under
the Company's 2021 Long-term Incentive Plan ("LTIP") to a Person Discharging
Managerial Responsibilities ("PDMR"):

 PDMR         Number of shares under option
 Mark Davies  886,824

 

The number of nil-cost options was calculated by reference to a price of
£0.9472, being the average of the closing middle market quotations for the
Company's ordinary shares on 7 May 2024, 3 May 2024 and 2 May 2024.

The nil-cost options will normally vest on the third anniversary of grant,
subject to the attainment of performance conditions.  The Remuneration
Committee has the discretion to adjust the awards downwards at vesting for
malus reasons.  Details of the operation of the LTIP are set out in the
Company's 2023 Report and Accounts.

Details of the transaction referenced above are included below in accordance
with Article 19 of the retained EU law version of the Market Abuse Regulation
(Regulation 596/2014).

 1    Details of Person Discharging Managerial Responsibility/person closely
      associated with them ("PCA")
 (a)  Name                                     Mark Davies

 2    Reason for the notification
 (a)  Position/status                          Chief Executive Officer
 (b)  Initial notification/ amendment          Initial notification

 3    Details of the issuer, emission allowance market participant, auction
      platform, auctioneer or auction monitor

 (a)  Name                                     Primary Health Properties PLC

 (b)  LEI                                      213800Y5CJHXOATK7X11

 4    Details of the transaction(s): section to be repeated for (i) each type of
      instrument; (ii) each type of transaction; (iii) each date: and (iv) each
      place where transactions have been conducted
 (a)  Description of the financial instrument  Ordinary shares of 12.5p

                                               ISIN: GB00BYRJ5J14
 (b)  Nature of the transaction                Award of nil-cost options over the Company's ordinary shares

 (c)  Price(s) and volume(s)                   Price(s)                         Volume(s)
      Nil cost                                                                  886,824

 (d)  Aggregated volume price                  Single transaction: N/A

 (e)  Date of transaction                      8 May 2024

 (f)  Place of transaction                     n/a

 

More information on Primary Health Properties PLC can be found on
www.phpgroup.co.uk (//www.phpgroup.co.uk)

 

Further details:

 Richard Howell                                               Toby Newman

 Chief Financial Officer                                      Company Secretary & Chief Legal Officer

 Tel: +44 (0) 776 6072 272                                    Tel: +44 (0) 772 9047 959
 David Rydell / Stephanie Whitmore (Buchanan Communications)

 Tel: +44 (0) 20 7466 5066

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBDGDURBGDGSC